President’s Message:

Support for Continuing Professional Development is at the heart of the BTS mission.  To that end, in recent years we have partnered with the American College of Toxicology (ACT) to deliver training webinars and the course Practical Application of Toxicology in Drug Development (PATDD), which was held July 17-22 2017 at the Moeller Centre, Churchill College Cambridge.

This is the fourth year that the PATDD course has been held in the UK.  The course has grown in numbers and reputation over these 4 years and was again very successful this year as judged by the record attendance (45 participants) and very positive feedback from both students and instructors.  As in previous years, the students brought very diverse backgrounds and widely different levels of experience and travelled from 12 countries spread across three continents.

Students gain an in-depth knowledge base of toxicology as applied in nonclinical safety evaluation of new medicines and depart with a much enhanced appreciation of the role of toxicology in drug development for use in their current or future position.

Attendance at this course at a reduced rate is one of the many benefits offered to members of BTS or ACT.

I would like to thank my colleagues on the organizing committee of this course (Norman Kim, Roivant Sciences, Inc. and Hanan Ghantous, U.S. FDA), all of the instructors, educational funding supporters (Charles River Laboratories, Concept Life Sciences and Novo Nordisk) and the course administrators, Steve Hewitt (on behalf of BTS) and Jordan Ballance (on behalf of ACT).

Ernie Harpur

Tweets by ‎@BritToxSoc